166 related articles for article (PubMed ID: 16855786)
1. The Polycomb group protein Enhancer of Zeste 2: its links to DNA repair and breast cancer.
Zeidler M; Kleer CG
J Mol Histol; 2006 Sep; 37(5-7):219-23. PubMed ID: 16855786
[TBL] [Abstract][Full Text] [Related]
2. EZH2 and cancer stem cells: fact or fiction?
Crea F
Epigenomics; 2011 Apr; 3(2):127-8. PubMed ID: 22122274
[No Abstract] [Full Text] [Related]
3. EZH2 methyltransferase and H3K27 methylation in breast cancer.
Yoo KH; Hennighausen L
Int J Biol Sci; 2012; 8(1):59-65. PubMed ID: 22211105
[TBL] [Abstract][Full Text] [Related]
4. EZH2 regulates the transcription of estrogen-responsive genes through association with REA, an estrogen receptor corepressor.
Hwang C; Giri VN; Wilkinson JC; Wright CW; Wilkinson AS; Cooney KA; Duckett CS
Breast Cancer Res Treat; 2008 Jan; 107(2):235-42. PubMed ID: 17453341
[TBL] [Abstract][Full Text] [Related]
5. The Polycomb group protein EZH2 impairs DNA repair in breast epithelial cells.
Zeidler M; Varambally S; Cao Q; Chinnaiyan AM; Ferguson DO; Merajver SD; Kleer CG
Neoplasia; 2005 Nov; 7(11):1011-9. PubMed ID: 16331887
[TBL] [Abstract][Full Text] [Related]
6. The transcriptional repressor NIPP1 is an essential player in EZH2-mediated gene silencing.
Nuytten M; Beke L; Van Eynde A; Ceulemans H; Beullens M; Van Hummelen P; Fuks F; Bollen M
Oncogene; 2008 Feb; 27(10):1449-60. PubMed ID: 17724462
[TBL] [Abstract][Full Text] [Related]
7. Enhancer of Zeste 2 as a marker of preneoplastic progression in the breast.
Ding L; Kleer CG
Cancer Res; 2006 Oct; 66(19):9352-5. PubMed ID: 17018586
[TBL] [Abstract][Full Text] [Related]
8. Repression of E-cadherin by the polycomb group protein EZH2 in cancer.
Cao Q; Yu J; Dhanasekaran SM; Kim JH; Mani RS; Tomlins SA; Mehra R; Laxman B; Cao X; Yu J; Kleer CG; Varambally S; Chinnaiyan AM
Oncogene; 2008 Dec; 27(58):7274-84. PubMed ID: 18806826
[TBL] [Abstract][Full Text] [Related]
9. [Recent advances on EZH2 in malignant tumors].
Li J; Fan QH
Zhonghua Bing Li Xue Za Zhi; 2009 Dec; 38(12):856-8. PubMed ID: 20193471
[No Abstract] [Full Text] [Related]
10. Integration of estrogen and Wnt signaling circuits by the polycomb group protein EZH2 in breast cancer cells.
Shi B; Liang J; Yang X; Wang Y; Zhao Y; Wu H; Sun L; Zhang Y; Chen Y; Li R; Zhang Y; Hong M; Shang Y
Mol Cell Biol; 2007 Jul; 27(14):5105-19. PubMed ID: 17502350
[TBL] [Abstract][Full Text] [Related]
11. Distinctive expression of the polycomb group proteins Bmi1 polycomb ring finger oncogene and enhancer of zeste homolog 2 in nonsmall cell lung cancers and their clinical and clinicopathologic significance.
Kikuchi J; Kinoshita I; Shimizu Y; Kikuchi E; Konishi J; Oizumi S; Kaga K; Matsuno Y; Nishimura M; Dosaka-Akita H
Cancer; 2010 Jun; 116(12):3015-24. PubMed ID: 20564407
[TBL] [Abstract][Full Text] [Related]
12. The EZH2 polycomb transcriptional repressor--a marker or mover of metastatic prostate cancer?
Sellers WR; Loda M
Cancer Cell; 2002 Nov; 2(5):349-50. PubMed ID: 12450788
[TBL] [Abstract][Full Text] [Related]
13. Epigenetic control of hematopoietic stem cell aging the case of Ezh2.
De Haan G; Gerrits A
Ann N Y Acad Sci; 2007 Jun; 1106():233-9. PubMed ID: 17332078
[TBL] [Abstract][Full Text] [Related]
14. The Polycomb group protein EZH2 directly controls DNA methylation.
Viré E; Brenner C; Deplus R; Blanchon L; Fraga M; Didelot C; Morey L; Van Eynde A; Bernard D; Vanderwinden JM; Bollen M; Esteller M; Di Croce L; de Launoit Y; Fuks F
Nature; 2006 Feb; 439(7078):871-4. PubMed ID: 16357870
[TBL] [Abstract][Full Text] [Related]
15. Importance of Ezh2 polycomb protein in tumorigenesis process interfering with the pathway of growth suppressive key elements.
Tonini T; D'Andrilli G; Fucito A; Gaspa L; Bagella L
J Cell Physiol; 2008 Feb; 214(2):295-300. PubMed ID: 17786943
[TBL] [Abstract][Full Text] [Related]
16. EZH2-mediated epigenetic repression of DNA repair in promoting breast tumor initiating cells.
Stefansson OA; Esteller M
Breast Cancer Res; 2011 May; 13(3):309. PubMed ID: 21672285
[TBL] [Abstract][Full Text] [Related]
17. The transcriptional repression by NIPP1 is mediated by Polycomb group proteins.
Roy N; Van Eynde A; Beke L; Nuytten M; Bollen M
Biochim Biophys Acta; 2007; 1769(9-10):541-5. PubMed ID: 17804093
[TBL] [Abstract][Full Text] [Related]
18. EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells.
Kleer CG; Cao Q; Varambally S; Shen R; Ota I; Tomlins SA; Ghosh D; Sewalt RG; Otte AP; Hayes DF; Sabel MS; Livant D; Weiss SJ; Rubin MA; Chinnaiyan AM
Proc Natl Acad Sci U S A; 2003 Sep; 100(20):11606-11. PubMed ID: 14500907
[TBL] [Abstract][Full Text] [Related]
19. Context-specific regulation of NF-κB target gene expression by EZH2 in breast cancers.
Lee ST; Li Z; Wu Z; Aau M; Guan P; Karuturi RK; Liou YC; Yu Q
Mol Cell; 2011 Sep; 43(5):798-810. PubMed ID: 21884980
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical analysis of polycomb group protein expression in advanced gastric cancer.
Lee H; Yoon SO; Jeong WY; Kim HK; Kim A; Kim BH
Hum Pathol; 2012 Oct; 43(10):1704-10. PubMed ID: 22520951
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]